Ondansetron vs Tofacitinib
Ondansetron vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Ondansetron and Tofacitinib.
Mechanism of Action
Ondansetron: Selective 5-HT3 receptor antagonist.
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Ondansetron β 3-5 hours; Tofacitinib β 3.2 hours.
Chemical Properties
Molecular Formula: Ondansetron β C18H19N3O; Tofacitinib β C16H20N6O.
Molecular Weight: Ondansetron β 293.3660 g/mol; Tofacitinib β 312.3700 g/mol.
Type: Ondansetron β Small molecule; Tofacitinib β Small molecule.